These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 22985025)

  • 21. [Expression of matrix metalloproteinase and tissue inhibitor of metalloproteinase in adenomyosis].
    Qiu F; Gao XM; Luo GL; Yang KX; Wang H; Liu H; Wen Y
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2006 Jan; 37(1):118-22. PubMed ID: 16468658
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Polymorphisms in the promoter regions of the matrix metalloproteinases-7, -9 and the risk of endometriosis and adenomyosis in China.
    Shan K; Lian-Fu Z; Hui D; Wei G; Na W; Xia J; Yan L
    Mol Hum Reprod; 2006 Jan; 12(1):35-9. PubMed ID: 16455621
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of the transforming growth factor beta1 gene -509 C/T polymorphism in patients with advanced-stage endometriosis.
    Kim JJ; Choi YM; Choung SH; Yoon SH; Lee KS; Ku SY; Kim JG; Moon SY
    Fertil Steril; 2010 May; 93(7):2121-4. PubMed ID: 19249027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A haplotype constituted of four MMP-2 promoter polymorphisms (-1575G/A, -1306C/T, -790T/G and -735C/T) is associated with coronary triple-vessel disease.
    Vasků A; Goldbergová M; Izakovicová Hollá L; Sisková L; Groch L; Beránek M; Tschöplová S; Znojil V; Vácha J
    Matrix Biol; 2004 Jan; 22(7):585-91. PubMed ID: 14996438
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of polymorphisms of the MMP-2 and TIMP-2 genes with the risk of endometriosis in North Chinese women.
    Kang S; Zhao XW; Wang N; Chen SC; Zhou RM; Li Y
    Fertil Steril; 2008 Nov; 90(5):2023-9. PubMed ID: 18177649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Genetic polymorphisms of matrix metalloproteinase 12 and 13 genes are implicated in endometriosis progression.
    Borghese B; Chiche JD; Vernerey D; Chenot C; Mir O; Bijaoui G; Bonaiti-Pellié C; Chapron C
    Hum Reprod; 2008 May; 23(5):1207-13. PubMed ID: 18308831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Matrix metalloproteinase (MMP)-2 gene polymorphisms affect circulating MMP-2 levels in patients with migraine with aura.
    Gonçalves FM; Martins-Oliveira A; Lacchini R; Belo VA; Speciali JG; Dach F; Tanus-Santos JE
    Gene; 2013 Jan; 512(1):35-40. PubMed ID: 23043936
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of FCRL3 -169T/C polymorphism with endometriosis and identification of a protective haplotype against the development of the disease in Brazilian population.
    Bianco B; Teles JS; Lerner TG; Vilarino FL; Christofolini DM; Barbosa CP
    Hum Immunol; 2011 Sep; 72(9):774-8. PubMed ID: 21663782
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The GC + CC genotype at position -418 in TIMP-2 promoter and the -1575GA/-1306CC genotype in MMP-2 is genetic predisposing factors for prevalence of moyamoya disease.
    Park YS; Jeon YJ; Kim HS; Han IB; Oh SH; Kim DS; Kim NK
    BMC Neurol; 2014 Oct; 14():180. PubMed ID: 25280484
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Genetic polymorphisms of the matrix metalloproteinase-3 (MMP-3) and tissue inhibitors of matrix metalloproteinases-1 (TIMP-1) modulate the development of ankylosing spondylitis.
    Wei JC; Lee HS; Chen WC; Shiu LJ; Yang SF; Wong RH
    Ann Rheum Dis; 2009 Nov; 68(11):1781-6. PubMed ID: 19019896
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polymorphisms in the matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 and the risk of human adenomyosis.
    Kang S; Zhao X; Xing H; Wang N; Zhou R; Chen S; Li W; Zhao J; Duan Y; Sun D; Li Y
    Environ Mol Mutagen; 2008 Apr; 49(3):226-31. PubMed ID: 18288718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A common matrix metalloproteinase (MMP)-2 polymorphism affects plasma MMP-2 levels in subjects environmentally exposed to mercury.
    Jacob-Ferreira AL; Lacchini R; Gerlach RF; Passos CJ; Barbosa F; Tanus-Santos JE
    Sci Total Environ; 2011 Sep; 409(20):4242-6. PubMed ID: 21794897
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host single nucleotide polymorphisms of MMP-9 -1562/TIMP-1 372 have gender differences in the risk of gastric intestinal metaplasia after Helicobacter pylori infection.
    Hung KH; Hung HW; Yang HB; Lu CC; Wu JJ; Sheu BS
    Helicobacter; 2009 Dec; 14(6):580-7. PubMed ID: 19889076
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms in the Promoters of the MMP-2 and TIMP-2 Genes Are Associated with Spontaneous Deep Intracerebral Hemorrhage in the Taiwan Population.
    Chen YC; Ho WM; Lee YS; Chen HW; Chen CM
    PLoS One; 2015; 10(11):e0142482. PubMed ID: 26551785
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gelatinase A (MM-2), gelatinase B (MMP-9) and their inhibitors (TIMP 1, TIMP-2) in serum of women with endometriosis: Significant correlation between MMP-2, MMP-9 and their inhibitors without difference in levels of matrix metalloproteinases and tissue inhibitors of metalloproteinases in relation to the severity of endometriosis.
    Salata IM; Stojanovic N; Cajdler-Łuba A; Lewandowski KC; Lewiński A
    Gynecol Endocrinol; 2008 Jun; 24(6):326-30. PubMed ID: 18584412
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between susceptibility to advanced stage endometriosis and the genetic polymorphisms of aryl hydrocarbon receptor repressor and glutathione-S-transferase T1 genes.
    Kim SH; Choi YM; Lee GH; Hong MA; Lee KS; Lee BS; Kim JG; Moon SY
    Hum Reprod; 2007 Jul; 22(7):1866-70. PubMed ID: 17513317
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matrix metalloproteinases in premature coronary atherosclerosis: influence of inhibitors, inflammation, and genetic polymorphisms.
    Nanni S; Melandri G; Hanemaaijer R; Cervi V; Tomasi L; Altimari A; Van Lent N; Tricoci P; Bacchi L; Branzi A
    Transl Res; 2007 Mar; 149(3):137-44. PubMed ID: 17320799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Association of polymorphism in matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 with genetic susceptibility of gastric cancer].
    Lin XD; Chen G; Li C; Zhang LY; Shi Y; Zhou DM; Zheng XW
    Zhonghua Yu Fang Yi Xue Za Zhi; 2011 Aug; 45(8):711-6. PubMed ID: 22169692
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional haplotypes in the promoter of matrix metalloproteinase-2 predict risk of the occurrence and metastasis of esophageal cancer.
    Yu C; Zhou Y; Miao X; Xiong P; Tan W; Lin D
    Cancer Res; 2004 Oct; 64(20):7622-8. PubMed ID: 15492291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Associations between various possible promoter polymorphisms of MMPs genes and endometriosis risk: a meta-analysis.
    Yang H; Liu J; Fan Y; Guo Q; Ge L; Yu N; Zheng X; Dou Y; Zheng S
    Eur J Obstet Gynecol Reprod Biol; 2016 Oct; 205():174-88. PubMed ID: 27620811
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.